If you are age 21-40, you may qualify for an influenza research study to develop a vaccine that provides rapid protections to younger adults against influenza A virus.

No vaccine will be given in this study.

Participants will receive travel compensation.

For more information, contact Sue Doyle, LPN at 1-877-274-4645.